Search

Your search keyword '"Eichler, K."' showing total 267 results
Start Over Author "Eichler, K." Publication Year Range Last 10 years
267 results on '"Eichler, K."'

2. 03.04 Targeted disruption of tumor-borne GDF-15-mediated immunoresistance restores immune checkpoint inhibitor activity in last-line cancer patients

Author

Haake, M, primary, Vashist, N, additional, Eichler, K, additional, Kist, M, additional, Genßler, S, additional, Giese, I, additional, Weigandt, J, additional, Klar, K, additional, Fettes, P, additional, Ross, T, additional, Wischhusen, J, additional, Leo, E, additional, and Schuberth-Wagner, C, additional

Published
2024
Full Text
View/download PDF

6. Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011–2015

Author

Blozik E, Rapold R, Eichler K, and Reich O

Subjects
Multiple sclerosis, prevalence, incidence, epidemiology, costs, claims data, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571, Neurology. Diseases of the nervous system, RC346-429
Abstract

Eva Blozik,1–3 Roland Rapold,1 Klaus Eichler,4 Oliver Reich1 1Department of Health Sciences, Helsana Group, Zürich, Switzerland; 2Institute of General Practice, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 3Division of General Practice, University Medical Center Freiburg, Freiburg, Germany; 4Winterthur Institute of Health Economics, Zurich University of Applied Sciences, Winterthur, Switzerland Background: Medical therapy for multiple sclerosis (MS) is expensive. Quantifying the burden of MS is fundamental for health-care planning and the allocation of resources for the management of MS. This study provides current national estimates of prevalence, incidence, mortality, and costs of MS in Switzerland using claims data between 2011 and 2015. Methods: We analyzed health insurance claims of adult persons enrolled with a large health insurance group covering about 13% of the Swiss population between 2011 and 2015. The identification of patients with MS was based on prescription data of MS-specific medication using the Anatomical Therapeutic Chemical Classification system as proxy for clinical diagnosis. We estimated prevalence, mortality, and costs of basic health insurance between 2011 and 2015. Furthermore, incidence of MS was calculated for 2015. All results were weighted with census data to achieve an extrapolation to the Swiss general population level. Cost of illness was estimated as direct medical cost from the perspective of a Swiss health insurance using multivariate linear regression analysis. Results: Of the 943,639 subjects in the year 2015, 1,606 were identified as MS patients resulting in a prevalence of 190 per 100,000 (95% CI: 180-190 per 100,000). Incidence was 16 per 100,000 (95% CI: 13-19 per 100,000). According to regression analysis, the total cost of illness for basic mandatory health insurance was 26,710 Swiss Francs (CHF) (95% CI: 26,100–27,300) per person per year with the cost of medication being almost identical 26,960 CHF (95% CI: 26,170–27,800). Conclusions: MS affects 10,000–15,000 persons in Switzerland, and the prevalence has increased over the last 22 years. These persons have high need and demand for health care. High costs are primarily due to expenses for medication. Given the imbalance of MS medication therapy from the perspective of basic health insurance on the disposable resources, it is crucial to increase transparency related to the volume, type, and allocation of expenses. Keywords: health insurance, Switzerland, medication, prescription, management, resources

Published
2017

19. Comparison of contrast-enhanced videofluoroscopy to unenhanced dynamic MRI in minor patients following surgical correction of velopharyngeal dysfunction

Author

Arendt, C. T., primary, Eichler, K., additional, Mack, M. G., additional, Leithner, D., additional, Zhang, S., additional, Block, K. T., additional, Berdan, Y., additional, Sader, R., additional, Wichmann, J. L., additional, Gruber-Rouh, T., additional, Vogl, T. J., additional, and Hoelter, M. C., additional

Published
2020
Full Text
View/download PDF

24. Gesundheitsökonomischer Impact der AO Foundation in der Behandlung von Frakturen

Author

Eichler, K, Höglinger, M, Meier, F, Denk, E, Gutzwiller, F, Prein, J, Renner, N, and Joeris, A

Subjects
ddc: 610, Kosten, Gesundheitsökonomie, Frakturen, Osteosnthese, 610 Medical sciences, Medicine, Produktivitätsverluste
Abstract

Fragestellung: Die Osteosynthese (OS) wurde durch die AO (Arbeitsgemeinschaft für Osteosynthesefragen) in den 1950-er Jahren in der Schweiz eingeführt. Die OS hat die Frakturbehandlung weltweit revolutioniert. Erstaunlicherweise wurde bisher keine formale Impact-Analyse für diese Technologie[zum vollständigen Text gelangen Sie über die oben angegebene URL], Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2019)

Published
2019
Full Text
View/download PDF

48. Schraubenfehllagen und Korrekturbedürftigkeit bei der navigierten Instrumentation an der Brust- und Lendenwirbelsäule – Eine Analyse von 1195 Pedikelschrauben

Author

El Saman, A, Meier, SL, Sander, AL, Eichler, K, Laurer, H, and Marzi, I

Subjects
ddc: 610, Schraubenfehllage, Pedikelschraube, 610 Medical sciences, Medicine, Navigation
Abstract

Fragestellung: Seit 1994 gewinnen Navigationsverfahren in der Wirbelsäulentraumatologie zunehmend an Bedeutung. Insbesondere für Instrumentierungen an der oberen BWS bringen computerassistierte Verfahren einen Vorteil bei schlechter Darstellbarkeit der zu besetzenden Pedikel in der Durchleuchtung.[zum vollständigen Text gelangen Sie über die oben angegebene URL], Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2015)

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results